Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

<< Previous

Bullboard Posts

Next >>

Post by Donnuton Mar 31, 2021 8:19am

145 Views

Post# 32912472

New Way of Eating

This just came in the news! people might have been becoming more and more health conscious. As a potential result, they could be turning into superfoods and mushrooms. Read how these modern foods could change how we eat in the future!

It was reported that in an effort to address specific health concerns and performance needs, boost immune systems, changing day-to-day productivity, and even focus, millions of people might be turning to superfoods and functional mushrooms. For market bearers, this could be the best part. These millions of people could be creating a juggernaut of a market!

Due to this phenomenon, the functional food market could be worth roughly $275.77 billion in about 2025, and could develop at a whopping around 7.9% annually! This is a sponsored. Check disclaimer on profile and landing page.

<< Previous

Bullboard Posts

Next >>

Nintendo stock hits new all-time high as excitement builds over Switch successor